Dougherty Wealth Advisers’s AbbVie ABBV Stock Holding History

Dougherty Wealth Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$131K	Hold	604	–	–	0.08%	56
2025 Q4	$138K	Hold	604	–	–	0.08%	60
2025 Q3	$140K	Hold	604	–	–	0.09%	52
2025 Q2	$112K	Hold	604	–	–	0.07%	57
2025 Q1	$127K	Hold	604	–	–	0.09%	53
2024 Q4	$107K	Hold	604	–	–	0.08%	58
2024 Q3	$119K	Sell	604 -38	-6%	-$7.09K	0.09%	52
2024 Q2	$110K	Hold	642	–	–	0.1%	53
2024 Q1	$117K	Hold	642	–	–	0.1%	51
2023 Q4	$99.5K	Hold	642	–	–	0.09%	61
2023 Q3	$95.7K	Hold	642	–	–	0.11%	53
2023 Q2	$86.5K	Sell	642 -73	-10%	-$10.7K	0.12%	61
2023 Q1	$114K	Sell	715 -715	-50%	-$109K	0.17%	49
2022 Q4	$231K	Hold	1,430	–	–	0.38%	30
2022 Q3	$192K	Hold	1,430	–	–	0.38%	30
2022 Q2	$219K	Hold	1,430	–	–	0.41%	27
2022 Q1	$232K	Hold	1,430	–	–	0.35%	31
2021 Q4	$194K	Hold	1,430	–	–	0.27%	40
2021 Q3	$154K	Hold	1,430	–	–	0.23%	43
2021 Q2	$161K	Hold	1,430	–	–	0.24%	42
2021 Q1	$155K	Hold	1,430	–	–	0.23%	41
2020 Q4	$153K	Hold	1,430	–	–	0.24%	42
2020 Q3	$125K	Hold	1,430	–	–	0.43%	45
2020 Q2	$140K	Hold	1,430	–	–	0.51%	40
2020 Q1	$109K	Hold	1,430	–	–	0.43%	48
2019 Q4	$127K	Hold	1,430	–	–	0.39%	50
2019 Q3	$108K	Sell	1,430 -300	-17%	-$20.6K	0.36%	52
2019 Q2	$126K	Hold	1,730	–	–	0.36%	56
2019 Q1	$139K	Sell	1,730 -850	-33%	-$69.5K	0.47%	44
2018 Q4	$204K	Buy	+2,580	New	+$227K	0.67%	36

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dougherty Wealth Advisers's ABBV Position: Q1 2026 in Review

Dougherty Wealth Advisers held its AbbVie (ABBV) position steady in Q1 2026 at 604 shares worth $131K. The position accounts for 0.08% of the portfolio, ranked #56.

Dougherty Wealth Advisers first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $232K in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Dougherty Wealth Advisers held 604 shares of AbbVie worth $131K as of Q1 2026.
Dougherty Wealth Advisers left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.08% of Dougherty Wealth Advisers's portfolio in Q1 2026, its #56 holding.
Dougherty Wealth Advisers first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
Dougherty Wealth Advisers's AbbVie position peaked at $232K in Q1 2022.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Dougherty Wealth Advisers's 13F filing for Q1 2026, filed 21 Apr 2026.